Search

everythinglearnresearchcommunity

for

Search:↓

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

New understanding of the causes of primary cicatricial alopecia has led to better diagnosis and potential new treatments.

Drug repositioning is becoming more targeted and efficient with new technologies, offering personalized treatment options and growing interest in the field.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

PDGF signaling is crucial for maintaining and renewing hair follicle stem cells, which could help treat hair loss.

Organoids can help study COVID-19 and develop treatments, but face challenges like instability and limited renewal.

New treatments targeting skin stem cells show promise for skin repair, anti-aging, and cancer therapy.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

The document explains hair biology, the causes of hair loss, and reviews various hair loss treatments.

MicroRNAs are important for skin health and could be targets for new skin disorder treatments.

Some stem cells in the body rarely divide, which could help create better treatments for diseases and aging.

Minoxidil dissolves better in propylene glycol + water than in supercritical CO2.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.

Chronic kidney disease can cause skin problems that affect patient quality of life, and treating these conditions can improve outcomes.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

FDG PET/CT scans can change cancer treatment plans for dogs.

A cancer drug called nilotinib might cause hair loss due to inflammation around hair follicles.

In Singapore, most skin reactions to drugs were in females and Chinese, often caused by painkillers, antibiotics, and some other drugs, with serious cases linked to genetics.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

TGF-β inhibitors may help treat liver fibrosis by targeting various pathways.

Proper skin toxicity management in chemotherapy is key to continuing treatment and keeping patient quality of life high.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

Ruxolitinib treatment may cause eyelash growth.

Sunlight exposure improved a patient's skin condition, and there may be a link between a certain disease and skin growths; a leukemia treatment caused changes in hair color and growth.

Spaceflight can harm skin health by altering gene expression, affecting DNA, mitochondria, and skin barriers.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.